Form 4: Director Laura Conigliaro Receives Genpact RSU Grant

Sentiment:

Statement of Changes in Beneficial Ownership


Genpact Limited director Laura Conigliaro was granted 6,521 restricted share units as part of the company's incentive compensation plan.

Summary

  • Director Laura Conigliaro acquired 6,521 restricted share units (RSUs) on April 23, 2026.
  • The grant was issued under the Genpact Limited 2017 Omnibus Incentive Compensation Plan.
  • Following this transaction, the reporting person's total beneficial ownership of common shares is 79,337.
  • The RSUs are subject to continued service requirements.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which carries a neutral sentiment.

Positives

  • The grant aligns the director's interests with long-term shareholder value through equity-based compensation.

Negatives

  • None identified.

Risks

  • Vesting is contingent upon the reporting person's continued service to the company.

Future Outlook

The RSUs will fully vest on December 31, 2026, and will be settled in common shares on December 31, 2027, provided the director remains in service.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard corporate governance practice to ensure alignment between board oversight and shareholder interests in the professional services and IT consulting sector.

Comparison to Industry Standards

  • The use of a 2017 Omnibus Incentive Compensation Plan is consistent with standard equity compensation structures for S&P 500 and mid-cap technology firms.
  • The vesting schedule of approximately 20 months is typical for director-level equity retention programs.

Stakeholder Impact

  • Minimal impact on shareholders as this is a standard compensation event for a board member.

Next Steps

  • Vesting of RSUs on December 31, 2026.
  • Settlement of shares on December 31, 2027.

Key Dates

DateDescription
04/23/2026Date of the RSU grant transaction.
04/27/2026Date the Form 4 was signed and filed.
12/31/2026Vesting date for the granted RSUs.
12/31/2027Settlement date for the common shares.

Keywords

Genpact, Form 4, Insider Trading, Director Compensation, Equity Incentive Plan, G

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.